These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33976658)

  • 1. Frontal Hypoperfusion and the Effectiveness of Perampanel in Long-Lived Patient with Lafora Disease.
    Obara K; Abe E; Toyoshima I
    Case Rep Neurol; 2021; 13(1):211-217. PubMed ID: 33976658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease).
    Schorlemmer K; Bauer S; Belke M; Hermsen A; Klein KM; Reif PS; Oertel WH; Kunz WS; Knake S; Rosenow F; Strzelczyk A
    Epilepsy Behav Case Rep; 2013; 1():118-21. PubMed ID: 25667843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel.
    Dirani M; Nasreddine W; Abdulla F; Beydoun A
    Epilepsy Behav Case Rep; 2014; 2():164-6. PubMed ID: 25667898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of perampanel in ten patients with Lafora disease.
    Goldsmith D; Minassian BA
    Epilepsy Behav; 2016 Sep; 62():132-5. PubMed ID: 27459034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of the successful treatment of severe myoclonus with Lance-Adams syndrome by add-on perampanel showing long term effects].
    Saito K; Oi K; Inaba A; Kobayashi M; Ikeda A; Wada Y
    Rinsho Shinkeigaku; 2021 Jan; 61(1):18-23. PubMed ID: 33328418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3.
    Tahara M; Higurashi N; Narita A; Ida H
    Brain Dev; 2022 Apr; 44(4):308-312. PubMed ID: 34991910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
    Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
    Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
    [No Abstract]   [Full Text] [Related]  

  • 8. Lafora disease: severe phenotype associated with homozygous deletion of the NHLRC1 gene.
    Kecmanović M; Jović N; Cukić M; Keckarević-Marković M; Keckarević D; Stevanović G; Romac S
    J Neurol Sci; 2013 Feb; 325(1-2):170-3. PubMed ID: 23317923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presenting symptoms of Lafora Disease: An electroclinical and genetic study in five Apulian (Southern Italy) families.
    d'Orsi G; Lalla A; Palumbo O; Di Claudio MT; Valenzano A; Sabetta A; Lopopolo A; Muro ED; Palumbo P; Copetti M; Carella M; Avolio C
    Seizure; 2020 Dec; 83():145-153. PubMed ID: 33152654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lance-Adams Syndrome Treated by Perampanel in the Acute Term.
    Katsuki M; Narita N; Yasuda I; Tominaga T
    Cureus; 2021 Mar; 13(3):e13761. PubMed ID: 33842137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lafora disease: a case report.
    Zeka N; Zogaj L; Gerguri A; Bejiqi R; Ratkoceri R; Maloku A; Mustafa A; Shahini L; Maxharaj J
    J Med Case Rep; 2022 Oct; 16(1):360. PubMed ID: 36192771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visualization of epileptic lesions using single photon emission computed tomography (SPECT) with N-isopropyl-p-(123I) iodoamphetamine after intravenous loading of bemegride--report of a case].
    Kawamura M; Murase K; Yasuhara Y; Mogami H; Tanada S; Hamamoto K; Hatakeyama T; Kimura H; Sakaki S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Feb; 49(2):199-205. PubMed ID: 2787907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose perampanel improved cortical myoclonus and basophobia in a patient with Unverricht-Lundborg disease: a case report].
    Oi Y; Kobayashi K; Hitomi T; Matsumoto R; Ikeda A; Takahashi R
    Rinsho Shinkeigaku; 2018 Oct; 58(10):622-625. PubMed ID: 30270337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perampanel Improves Cortical Myoclonus and Disability in Progressive Myoclonic Epilepsies: A Case Series and a Systematic Review of the Literature.
    Assenza G; Nocerino C; Tombini M; Di Gennaro G; D'Aniello A; Verrotti A; Marrelli A; Ricci L; Lanzone J; Di Lazzaro V; Bilo L; Coppola A
    Front Neurol; 2021; 12():630366. PubMed ID: 33841303
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies.
    Piña-Garza JE; Rosenfeld W; Saeki K; Villanueva V; Yoshinaga H; Patten A; Williams B; Malhotra M
    Epilepsy Behav; 2020 Mar; 104(Pt A):106876. PubMed ID: 31954998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of perampanel in children and adults with various epilepsy syndromes: A single-center postmarketing study.
    Singh K; Shah YD; Luciano D; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Aug; 61():41-45. PubMed ID: 27300147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
    Rektor I; Krauss GL; Inoue Y; Kaneko S; Williams B; Patten A; Malhotra M; Laurenza A; Wechsler RT
    Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perampanel attenuates myoclonus in a patient with neuronal ceroid lipofuscinoses type 2 disease.
    Wong LC; Hsu CJ; Lee WT
    Brain Dev; 2019 Oct; 41(9):817-819. PubMed ID: 31122803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.
    Gil-López FJ; Montoya J; Falip M; Aparicio J; López-González FJ; Toledano R; Gil-Nagel A; Molins A; García I; Serrano P; Domenech G; Torres F; Donaire A; Carreño M
    Acta Neurol Scand; 2018 Aug; 138(2):122-129. PubMed ID: 29573400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric seizure termination in primary and secondary generalized tonic-clonic seizures.
    Walser G; Unterberger I; Dobesberger J; Embacher N; Falkenstetter T; Larch J; Kuchukhidze G; Gotwald T; Ortler M; Bauer G; Trinka E
    Epilepsia; 2009 Sep; 50(9):2035-9. PubMed ID: 19400875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.